TY - JOUR
T1 - LRRC37B is a human modifier of voltage-gated sodium channels and axon excitability in cortical neurons
AU - Libé-Philippot, Baptiste
AU - Lejeune, Amélie
AU - Wierda, Keimpe
AU - Louros, Nikolaos
AU - Erkol, Emir
AU - Vlaeminck, Ine
AU - Beckers, Sofie
AU - Gaspariunaite, Vaiva
AU - Bilheu, Angéline
AU - Konstantoulea, Katerina
AU - Nyitrai, Hajnalka
AU - De Vleeschouwer, Matthias
AU - Vennekens, Kristel M.
AU - Vidal, Niels
AU - Bird, Thomas W.
AU - Soto, Daniela C.
AU - Jaspers, Tom
AU - Dewilde, Maarten
AU - Dennis, Megan Y.
AU - Rousseau, Frederic
AU - Comoletti, Davide
AU - Schymkowitz, Joost
AU - Theys, Tom
AU - de Wit, Joris
AU - Vanderhaeghen, Pierre
N1 - Publisher Copyright:
© 2023 The Authors
PY - 2023/12/21
Y1 - 2023/12/21
N2 - The enhanced cognitive abilities characterizing the human species result from specialized features of neurons and circuits. Here, we report that the hominid-specific gene LRRC37B encodes a receptor expressed in human cortical pyramidal neurons (CPNs) and selectively localized to the axon initial segment (AIS), the subcellular compartment triggering action potentials. Ectopic expression of LRRC37B in mouse CPNs in vivo leads to reduced intrinsic excitability, a distinctive feature of some classes of human CPNs. Molecularly, LRRC37B binds to the secreted ligand FGF13A and to the voltage-gated sodium channel (Nav) β-subunit SCN1B. LRRC37B concentrates inhibitory effects of FGF13A on Nav channel function, thereby reducing excitability, specifically at the AIS level. Electrophysiological recordings in adult human cortical slices reveal lower neuronal excitability in human CPNs expressing LRRC37B. LRRC37B thus acts as a species-specific modifier of human neuron excitability, linking human genome and cell evolution, with important implications for human brain function and diseases.
AB - The enhanced cognitive abilities characterizing the human species result from specialized features of neurons and circuits. Here, we report that the hominid-specific gene LRRC37B encodes a receptor expressed in human cortical pyramidal neurons (CPNs) and selectively localized to the axon initial segment (AIS), the subcellular compartment triggering action potentials. Ectopic expression of LRRC37B in mouse CPNs in vivo leads to reduced intrinsic excitability, a distinctive feature of some classes of human CPNs. Molecularly, LRRC37B binds to the secreted ligand FGF13A and to the voltage-gated sodium channel (Nav) β-subunit SCN1B. LRRC37B concentrates inhibitory effects of FGF13A on Nav channel function, thereby reducing excitability, specifically at the AIS level. Electrophysiological recordings in adult human cortical slices reveal lower neuronal excitability in human CPNs expressing LRRC37B. LRRC37B thus acts as a species-specific modifier of human neuron excitability, linking human genome and cell evolution, with important implications for human brain function and diseases.
KW - FGF13
KW - LRRC37
KW - SCN1B
KW - axon initial segment
KW - cerebral cortex
KW - gene duplicates
KW - human brain evolution
KW - neuronal excitability
KW - voltage-gated channels
UR - http://www.scopus.com/inward/record.url?scp=85180605324&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85180605324&partnerID=8YFLogxK
U2 - 10.1016/j.cell.2023.11.028
DO - 10.1016/j.cell.2023.11.028
M3 - Article
C2 - 38134874
AN - SCOPUS:85180605324
SN - 0092-8674
VL - 186
SP - 5766-5783.e25
JO - Cell
JF - Cell
IS - 26
ER -